Join safety-minded colleagues at our first Medication Safety INTENSIVE (MSI) workshop this year on March 31 - April 1 in Orlando, FL. This hands-on workshop will help you learn to identify, analyze, and control medication safety risks using real-world case examples for practice. For more information, go to: www.ismp.org/educational/msi/.
A subcommittee of the Medication Safety Officers Society (MSOS) Guidelines Committee worked with ISMP staff to revise the ISMP Guidelines for Safe Preparation of Sterile Compounds that was originally published in 2013. We ask that MSOS members to please provide comments on the proposed revisions by April 10, 2016. To view the document and submit comments, please go to: www.ismp.org/tools/guidelines/spsc.
ISMP is now taking applications for its 2016-2017 ISMP Safe Medication Management Fellowship and ISMP/FDA Safe Medication Management Fellowship programs. Fellows are based in ISMP’s office in Horsham, PA, near Philadelphia, and over a course of 12 months help develop and implement interdisciplinary error-prevention strategies that focus on system analysis and effectively reduce the risk of medication errors. They also have the chance to collaborate on broad-base communication and education initiatives that reach healthcare professionals and the general public. The fellowships are open to U.S. citizens only. Please inform any interested parties. Applications for the 2016-2017 fellowships are due March 31, 2016. For more information, go to: www.ismp.org/profdevelopment/managementfellowship.asp
ISMP released its new 2016-2017 Targeted Medication Safety Best Practices for Hospitals. There are 5 new best practices related to neuromuscular blockers, smart pumps, antidotes/reversal agents, sterile water bags and sterile compounding (BP 7-11). In addition, two of the 2014-2015 best practices related to oral methotrexate (BP 2) and metric weights (BP 3) have been revised for 2016-2017 based on feedback over the past two years. The new document can be found on the ISMP website at www.ismp.org/tools/bestpractices/TMSBP-for-Hospitals.pdf. If you see the old document, you need to refresh your browser. Any questions about the new TMSBP can be directed to firstname.lastname@example.org.
MSOS would like to thank those who responded to the recent survey we sent to members who listed their role as a full-time or part-time medication safety officers (MSOs). The survey was intended to determine the bed size of the hospitals MSOs in which they work.
Based on a response rate of 21%, there was roughly an equal percentage of MSO’s who categorized the bed size of their facility as 151-300 beds, 301-450 beds, 451-750 beds, over 750 beds, and at the hospital system level. A very small percentage of MSOs (4%) worked in hospitals of 150 beds or less. Based on this survey, most MSO’s who are members of MSOS work in hospitals above 150 beds, and the majority do so in a full-time capacity.